FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046770130> ?p ?o ?g. }

• W2046770130 endingPage "153" @default.
• W2046770130 startingPage "146" @default.
• W2046770130 abstract "Treatment of human brain disease with erythropoietin (EPO) in order to achieve neuroprotection and/or neuroregeneration represents a totally new frontier in translational neuroscience. Rather than specifically targeting the cause of a particular disease entity, EPO nonspecifically influences components of the final common pathway that determine disease severity and progression in a number of entirely different brain diseases. EPO acts in an antiapoptotic, anti-inflammatory, antioxidant, neurotrophic, angiogenetic, stem cell-modulatory fashion. Importantly, it appears to influence neural plasticity. Most likely due to these properties, EPO has been found by many investigators to be protective or regenerative and to improve cognitive performance in various rodent models of neurological and psychiatric disease. The Göttingen-EPO-stroke trial has provided first promising data on humans for a neuroprotective therapy of an acute brain disease. Experimental EPO treatment to improve cognitive function in patients with schizophrenia represents a novel neuroregenerative strategy for a chronic brain disease. An exploratory trial in chronic progressive multiple sclerosis as an example of an inflammatory disease of the nervous system yielded first positive results of EPO treatment on both motor function and cognition. These promising results are just the beginning and will hopefully stimulate further work along these lines." @default.
• W2046770130 created "2016-06-24" @default.
• W2046770130 creator A5017586537 @default.
• W2046770130 creator A5046515885 @default.
• W2046770130 creator A5049386810 @default.
• W2046770130 creator A5069268891 @default.
• W2046770130 creator A5091006954 @default.
• W2046770130 date "2008-01-01" @default.
• W2046770130 modified "2023-10-17" @default.
• W2046770130 title "Recombinant Human Erythropoietin in the Treatment of Human Brain Disease: Focus on Cognition" @default.
• W2046770130 cites W128151115 @default.
• W2046770130 cites W1504583940 @default.
• W2046770130 cites W1533672300 @default.
• W2046770130 cites W1557296218 @default.
• W2046770130 cites W1584945551 @default.
• W2046770130 cites W189180901 @default.
• W2046770130 cites W1970916719 @default.
• W2046770130 cites W1973178224 @default.
• W2046770130 cites W1973802999 @default.
• W2046770130 cites W1974716477 @default.
• W2046770130 cites W1976229428 @default.
• W2046770130 cites W1976869427 @default.
• W2046770130 cites W1978726693 @default.
• W2046770130 cites W1980093324 @default.
• W2046770130 cites W1983911404 @default.
• W2046770130 cites W1988983923 @default.
• W2046770130 cites W1991317976 @default.
• W2046770130 cites W1995479486 @default.
• W2046770130 cites W1999582449 @default.
• W2046770130 cites W2012547110 @default.
• W2046770130 cites W2013177525 @default.
• W2046770130 cites W2015810508 @default.
• W2046770130 cites W2016934775 @default.
• W2046770130 cites W2017606827 @default.
• W2046770130 cites W2018039414 @default.
• W2046770130 cites W2018909644 @default.
• W2046770130 cites W2022123825 @default.
• W2046770130 cites W2023636188 @default.
• W2046770130 cites W2024882552 @default.
• W2046770130 cites W2029618402 @default.
• W2046770130 cites W2029705843 @default.
• W2046770130 cites W2034987918 @default.
• W2046770130 cites W2036970007 @default.
• W2046770130 cites W2037111471 @default.
• W2046770130 cites W2037526669 @default.
• W2046770130 cites W2038399499 @default.
• W2046770130 cites W2039274105 @default.
• W2046770130 cites W2039722135 @default.
• W2046770130 cites W2042367750 @default.
• W2046770130 cites W2042567975 @default.
• W2046770130 cites W2049305222 @default.
• W2046770130 cites W2051884508 @default.
• W2046770130 cites W2061252151 @default.
• W2046770130 cites W2066582680 @default.
• W2046770130 cites W2070921472 @default.
• W2046770130 cites W2078022765 @default.
• W2046770130 cites W2079863333 @default.
• W2046770130 cites W2081436764 @default.
• W2046770130 cites W2095313085 @default.
• W2046770130 cites W2095473686 @default.
• W2046770130 cites W2097294766 @default.
• W2046770130 cites W2103736834 @default.
• W2046770130 cites W2108089603 @default.
• W2046770130 cites W2109723592 @default.
• W2046770130 cites W2111144499 @default.
• W2046770130 cites W2115406568 @default.
• W2046770130 cites W2118218277 @default.
• W2046770130 cites W2118234034 @default.
• W2046770130 cites W2120231263 @default.
• W2046770130 cites W2122965222 @default.
• W2046770130 cites W2132850452 @default.
• W2046770130 cites W2133686401 @default.
• W2046770130 cites W2138751478 @default.
• W2046770130 cites W2142463112 @default.
• W2046770130 cites W2143058635 @default.
• W2046770130 cites W2147604739 @default.
• W2046770130 cites W2151480202 @default.
• W2046770130 cites W2151931971 @default.
• W2046770130 cites W2154285180 @default.
• W2046770130 cites W2161854192 @default.
• W2046770130 cites W2162264368 @default.
• W2046770130 cites W2168323957 @default.
• W2046770130 cites W2168867226 @default.
• W2046770130 cites W2175621407 @default.
• W2046770130 cites W2269763031 @default.
• W2046770130 cites W2315613377 @default.
• W2046770130 cites W2336116827 @default.
• W2046770130 cites W2339621165 @default.
• W2046770130 cites W43446693 @default.
• W2046770130 cites W84675279 @default.
• W2046770130 cites W87943494 @default.
• W2046770130 doi "https://doi.org/10.1053/j.jrn.2007.10.029" @default.
• W2046770130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18089462" @default.
• W2046770130 hasPublicationYear "2008" @default.
• W2046770130 type Work @default.
• W2046770130 sameAs 2046770130 @default.
• W2046770130 citedByCount "44" @default.
• W2046770130 countsByYear W20467701302012 @default.

• next